The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC related information was provided by the message!
  • No CSPEC computer assertion could be determined for this classification!

  • See Evidence submitted by expert panel for details.

Variant: NM_000138.5(FBN1):c.911G>A (p.Cys304Tyr)

CA392350265

495662 (ClinVar)

Gene: FBN1
Condition: Marfan syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: f2d90f19-8926-449c-b72b-96949362b243
Approved on: 2024-08-22
Published on: 2024-08-22

HGVS expressions

NM_000138.5:c.911G>A
NM_000138.5(FBN1):c.911G>A (p.Cys304Tyr)
NC_000015.10:g.48526207C>T
CM000677.2:g.48526207C>T
NC_000015.9:g.48818404C>T
CM000677.1:g.48818404C>T
NC_000015.8:g.46605696C>T
NG_008805.2:g.124582G>A
ENST00000559133.6:c.911G>A
ENST00000674301.2:c.911G>A
ENST00000316623.10:c.911G>A
ENST00000316623.9:c.911G>A
ENST00000537463.6:c.636+11504G>A
NM_000138.4:c.911G>A
More

Likely Pathogenic

Met criteria codes 5
PM1_Strong PM2_Supporting PP3 PP2 PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
NM_000138.5(FBN1):c. 911G>A is a missense variant in FBN1 predicted to cause a substitution of cysteine by tyrosine at amino acid 304 (p.Cys304Tyr). This variant was found in a proband with classical MFS with clinical Thoracic Aortic Dissection, Ectopia Lentis and a SS=7pt (Internal data Tokyo; PP4). This variant has been reported 1 time in ClinVar as Likely pathogenic and 1 time as uncertain significance (Variation ID: 632813). This variant is not present in gnomAD (PM2_Sup; https://gnomad.broadinstitute.org/ v4.1.0). This variant affects a cysteine residue in a calcium binding EGF domain. Cysteine residues are believed to be involved in the formation of disulfide bridges which are essential for the protein structure (PM1_strong). The constraint z-score for missense variants affecting FBN1 is 8.2 (gnomAD v.4.1.0, PP2). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (REVEL: 0.986, PP3). In summary, this variant meets criteria to be classified as Likely pathogenic for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PM1_Strong, PM2_Sup, PP4, PP3, PP2.
Met criteria codes
PM1_Strong
Cysteine affecting residue in cbEGF2 domain.
PM2_Supporting
Absent in gnomAD
PP3
REVEL score: 0.986
PP2
Missense variant in a gene that has a low rate of benign missense variation
PP4
Internal Data (Tokyo) : Found in a 39yo female with classical MFS with TAD, EL&SS=7pt.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.